期刊文献+

注意缺损多动障碍和儿茶酚-O-甲基转移酶基因无关联性(英文)

No Association Between Attention-Deficit Hyperactivity Disorder and Catechol-O-Methyltransferase Gene in Chinese
下载PDF
导出
摘要 以往研究表明,儿茶酚胺系统可能参于注意缺损多动障碍(attentiondeficithyperactivityitydisorder,ADHD)的发生,而儿茶酚胺O甲基转移酶(catechelomethyltransferase,COMT)是一种降解多巴胺和去甲肾上腺素系统的儿茶酚胺神经递质的酶。因此,采用两种以家系为基础的分析方法,即传递不平衡实验(transmissiondisequilibriumtest,TDT)和单倍型为基础的单倍型相对风险率(haplotypebasedhaplotyperelativerisk,HHRR)去探讨COMT和中国人群中79个ADHD核心家系的关联性,ADHD诊断符合DSMIV的诊断标准。TDT(χ2=1.03,df=1,P>0.05)和HHRR(χ2=1.08,df=1,P>0.05)两种方法的分析结果表明,COMT等位基因不能优先传递给ADHD儿童,提示在中国人群中ADHD与COMT基因无关联性。 Previous studies suggested that the catecholaminergic systems may be involved in the pathogenesis of attention-deficit hyperactivity disorder(ADHD), Since catechel-o-methyltransferase(COMT) is an enzyme involved in the degradation of catecholaminergic neurotransmitters of the dopaminergic and noradrenergic systems,it is possible that COMT may play a role in ADHD, To test this hypothesis,we used two family-based analyses,the transmission disequilibrium test (TDT) and the haplotype-based haplotype relative risk (HHRR), to examine the possible association between COMT gene and DSM-IV-diagnosed ADHD in a Chinese sample consisting of 79 ADHD probands and their parents. Both TDT (X^2 =1.03,df=1 ,P〉0. 05) and HHRR (X^2 =1.08,df= 1, P 〉 0.05) analyses failed to detect preferential transmission of a COMT allele to the ADHD children. Our data suggested that there was no association between ADHD and the COMT gene in the Chinese population.
出处 《Acta Genetica Sinica》 SCIE CAS CSCD 北大核心 2005年第8期784-788,共5页
基金 国家自然科学基金项目资助(编号:39970774)~~
关键词 注意缺损多动障碍 儿茶酚-O-甲基转移酶 传递不平衡实验(TDT) 单倍型为基础的单倍型相对风险率(HHRR) 关联性 甲基转移酶 儿茶酚胺 酶基因 缺损 去甲肾上腺素 attention-deficit hyperactivity disorder (ADHD) catechoI-O-methyltransferase (COMT) transmission disequnilibrium test (TDT) haplotype-based haplotype relative risk (HHRR) association
  • 相关文献

参考文献21

  • 1Biederman J. Attention-deficit/hyperactivity disorder: a lifespan perspective. J Clin Psychiatry, 1998.7:4 - 16.
  • 2Daly G ,Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1. DBH and DRD5 to affected children. Mol Psychiatry, 1999.4 : 192 - 196.
  • 3Chen C K,Chen S L,Mill J,Huang Y SoLin S KoCurran S.The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwan Residents sample. Mol Psychiatry,2003,8:393 - 396.
  • 4LaHoste G J,Swanson J MoWigal S B,Glabe CoWigal ToKing N. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry,1996,1:121 - 124.
  • 5Smalley S L, Bailey J N, Palmer C G, Cantwell D P, McGough J J,Del' Homme M A. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry, 1998.3 ;427 - 430.
  • 6Conners C K. Forty years of methylphenidate treatment in Attention-Deficit/Hyperactivity Disorder. J Atten Disord,2002,1 :S17 -S30.
  • 7Pliszka S R,Maas J W,Javors M A,Rogeness G A,Baker J. Urinary catecholamines in attention-deficit hyperactivity disorder wfth and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry, 1994,33 : 1165 - 1173.
  • 8Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K,Julkunen I. Kinetics of human soluble and membranebound catechol O-methyltransferase:a revised mechanism and description of the thermolabile variant of the enzyme.Biochemistry. 1995,34:4202 - 4210.
  • 9Lachman H M,Papolos D F,Saito T,Yu Y M,Szumlanski C L, Weinshilboum R M. Human catechol-O-methyltransferase pharmacogenetics:description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 1996,6:243 - 250.
  • 10Terwilliger J D. Ott J. A haplotype-based ' haplotype relatire risk' approach to detecting allelic associations. Hum Herod, 1992,42 : 337 - 346.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部